Evaluation on the PTP1B inhibition showed that the inhibitory effects of the prenylated xanthones are stronger that those of flavonoids, suggesting that the prenylated xanthones could be considered as a new class for the discovery and development of the PTP1B inhibition based anti-diabetic and anti-obesity drugs. This evidence concerns the gene PTPN1 and Obesity.